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Abstract
Multiple chemical sensitivity (MCS) is a disorder characterized by nonspecific and recurrent
symptoms from various organ systems associated with exposure to low levels of chemicals.
Patients with MCS process odors differently than controls do. Previously, we suggested that
this odor processing was associated with increased regional cerebral blood flow (rCBF) in
the prefrontal area during olfactory stimulation using near-infrared spectroscopic (NIRS)
imaging. The aim of this study was to investigate the association of odor thresholds and
changes in rCBF during olfactory stimulation at odor threshold levels in patients with MCS.
We investigated changes in the prefrontal area using NIRS imaging and a T&T olfactometer
during olfactory stimulation with two different odorants (sweet and fecal) at three concentra-
tions (zero, odor recognition threshold, and normal perceived odor level) in 10 patients with
MCS and six controls. The T&T olfactometer threshold test and subjective assessment of
irritating and hedonic odors were also performed. The results indicated that the scores for
both unpleasant and pungent odors were significantly higher for those for sweet odors at the
normal perceived level in patients with MCS than in controls. The brain responses at the rec-
ognition threshold (fecal odor) and normal perceived levels (sweet and fecal odors) were
stronger in patients with MCS than in controls. However, significant differences in the odor
detection and recognition thresholds and odor intensity score between the two groups were
not observed. These brain responses may involve cognitive and memory processing sys-
tems during past exposure to chemicals. Further research regarding the cognitive features
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of sensory perception and memory due to past exposure to chemicals and their associations
with MCS symptoms is needed.
Introduction
Multiple chemical sensitivity (MCS) is a disorder characterized by nonspecific and recurrent
symptoms from various organ systems associated with exposure to odorous chemicals [1–3].
The symptoms are reactions to previous exposure that recur during subsequent exposure to
the same or structurally unrelated chemicals at levels below those established to have harmful
effects in the general population [2].
The prevalence of self-reported chemical intolerance (CI) in population-based surveys
ranges from 8 to 33%, whereas that of physician-diagnosed MCS or reports of disabling conse-
quences in the form of social and occupational disruptions is much lower, ranging from 0.5 to
6.3% [4]. The most pertinent contributing factor to the large variability in estimated prevalence
is the wide variation in definitions for CI and MCS [4]. The Quick Environmental Exposure
Sensitivity Inventory (QEESI) that Miller and Prihoda developed [5] is a validated screening
scale for CI. Using the same cutoff scores for the QEESI provided a prevalence of CI of 8.2% in
a Danish population sample [6] and 7.5% in a Japanese population sample [7].
The symptoms of MCS can be mild to disabling, and they affect several organs, especially
the central nervous system, most frequently with patients complaining of headache, irritability,
and cognitive dysfunctions; additionally, the musculoskeletal, respiratory, and digestive sys-
tems are also frequently involved [2,8–11]. No precise definition of MCS has been established
and most definitions of MCS are qualitative, relying on subjective reports from patients and
clinicians of distressing symptoms and environmental exposure [3,4].
Several studies in the past decade uncovered regional cerebral blood flow (rCBF) distribu-
tion abnormalities in patients with MCS using single-photon emission computed tomography
(SPECT) [12] and positron emission tomography (PET) [13–15], especially while processing
odorous substances. In particular, patients with MCS were demonstrated to peculiarly react to
sensory stimuli, with activation of brain areas connected with motivational and emotional pro-
cessing of the information. We also demonstrated activation in the prefrontal cortex (PFC)
during olfactory stimulation [16] and in the orbitofrontal cortex (OFC) [17] following olfac-
tory stimulation in patients with MCS using several different odorants using near-infrared
spectroscopy (NIRS) imaging. These results suggest that prefrontal information processing
associated with odor-processing neuronal circuits and memory and cognition processes from
past hazardous chemical exposure play significant roles in the pathology of MCS [16,17].
These results also suggest that past strong exposure activates the PFC during olfactory stimula-
tion in patients with MCS, and strong OFC activation persists after stimulus exposure [17].
Thus, the chemical-sensitive state of patients with MCS might remain due to repeated daily
exposure, eventually leading to intolerance to odorous chemicals [17].
Recent studies regarding olfactory stimuli in patients with MCS evaluated their brain activi-
ties using PET more than 20 min after stimulus exposure for approximately 10 min [14,15].
However, the symptoms of patients with MCS often appear immediately after exposure to
chemicals. Thus, evaluating brain activities during olfactory stimulation is important for clari-
fying the pathology of this disorder. NIRS is an optical technique that provides a noninvasive
measure of continuous changes in rCBF during a task of the test. The spatial resolution of
NIRS is inferior to that of other functional neuroimaging such as fMRI (functional magnetic
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PLOS ONE | DOI:10.1371/journal.pone.0168006 December 9, 2016 2 / 16
decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
resonance imaging), PET, and SPECT. However, NIRS has the advantage of a high time reso-
lution and the feasibility of being performed under natural conditions. Thus, NIRS is suitable
for monitoring rCBF during olfactory stimulation testing.
Past provocation studies identified no clear dose–response relationship between exposure
and reaction in MCS [18]. Cullen defined MCS as an acquired disorder of recurrent symp-
toms, referable to multiple organ systems, occurring in response to chemically unrelated com-
pounds at much lower doses than those established in the general population to cause harmful
effects [1]. However, several provocation studies uncovered no objective differences between
patients with MCS and healthy controls regarding their reactions to chemical exposures at air
concentrations less than their health-based air quality guidelines and significantly less than
their odor thresholds [19–22].
The aim of this study was to investigate the association of odor thresholds and changes in
rCBF in the prefrontal area during olfactory stimulation at odor threshold levels in patients
with MCS, using NIRS imaging. To the best of our knowledge, few studies have investigated
this association using functional brain imaging in olfactory provocative testing.
Methods
Patients
Patients with MCS were diagnosed in the outpatient department (Outpatient Department of
Sick House Syndrome, Hyakumanben Clinic, Kyoto, Japan) for people with chemical sensitivi-
ties between October 2009 and January 2014. The same definitions for MCS used in our previ-
ous studies [16,17] were applied in this study. MCS was diagnosed according to the 1999
consensus criteria [23]. As described in detail previously [16,17], patients diagnosed with
chronic fatigue syndrome, fibromyalgia syndrome, or mental health disorders were excluded
from the study. Patients with hyperpiesia, hyperlipidemia, diabetes, and/or allergic rhinitis
were also excluded. The MCS condition of all patients was confirmed by the clinic physician
during recruitment, which was conducted 3 months prior to olfactory stimulation testing
using NIRS. Controls were recruited and selected to match the patients by age and sex at the
group level. The same inclusion and exclusion criteria were applied for all patients and con-
trols as those used in our previous studies [16,17]. Inclusion was based on QEESI scores,
whereas the exclusion criteria included abnormal hematological examinations, smoking, drug
or alcohol abuse, medications, pregnancy, and severe nasal stuffiness [16,17]. In addition, the
subjects who confirmed olfactory disturbance in the olfactory ability test to be hereinafter
described were excluded.
This study was approved by the ethical committee for human research at the Hyakumanben
Clinic (99642–61). This study was also approved by the ethical committee for human research
at the Louis Pasteur Centre for Medical Research (LPC.13). This study was performed accord-
ing to the guidelines of the Declaration of Helsinki. All patients provided written informed
consent and received the equivalent of 5000 JPY for their participation. This study was con-
ducted from October 2013 to January 2014.
Olfactory ability testing
Odor detection and recognition thresholds were determined using a T&T olfactometer (Daii-
chi. Yakuhin Sangyo, Ltd., Tokyo, Japan), which includes five odorants (odorant A [rose, light,
and sweet], β-phenyl ethyl alcohol; odorant B [caramel, burning], methyl cyclopentenolone;
odorant C [sweat], isovaleric acid; odorant D [fruits, heavy, and sweet], γ-undecalactone; and
odorant E [vegetable chips, fecal], skatole). T&T olfactometry is the standard Japanese olfac-
tory test, and it is routinely performed clinically [24,25]. Each odorant has eight degrees (log
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
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10 serial dilutions) of concentrations (−2 to 5) excluding odorant B (−2 to 4). This test kit is
used to determine of odor detection and recognition thresholds for each odorant [26,27].
The stimulus concentrations are presented in an ascending series and sniffed from strips of
blotter paper dipped into the odorant solutions by the examiner before sampling by the sub-
ject. The concentration at which a stimulus was first noticed (but usually not recognized) was
defined as the detection threshold, and the concentration at which the subject could identify
the odor was defined as the recognition threshold. Thus, the detection threshold is defined as
the lowest concentration detectable by the subject, whereas the recognition threshold is
defined as the lowest concentration at which the odor can be identified. The means of the
detection and recognition threshold values of the subcomponents of the test are used as the
dependent measures [28]. The detection and recognition thresholds for five odorants were
therefore averaged, and we used the values to evaluate olfactory acuities [27,29,30].
Odor recognition thresholds of 5.6 to 5.8, 1.1 to 5.5, and −2 to 1.0 were defined as ‘anosmia,’
‘hyposmia,’ and ‘normosmia,’ respectively, as the Japanese Olfactory Test Committee agreed
to use this criteria [31]. The detection and recognition thresholds approximately corresponded
to 0 and 1, respectively, in Japanese people [29].
Olfactory stimulation
In olfactory stimulation testing using NIRS imaging, the same T&T olfactometer was used in
this study. To avoid a strong and cumulative body burden on patients with MCS, the olfactory
stimulation test for each person was limited to total of six repetitions (two odorants and three
concentrations). As odorants that were commonly perceived during ordinary daily activities,
odorants D (γ-undecalactone [fruits, heavy, and sweet]) and E (skatole [vegetable chips, fecal])
were used in this study. The perception of these odors was assessed by placing the test strip of
blotter paper dipped into the odorant solutions at a distance of approximately 10 mm from the
noses of both patients with MCS and controls. The concentration levels of the odorants were
set at the odor recognition threshold (1) or normally perceived odor level (4), with a non-odor-
ant control (strip of blotter paper without odorant) used as placebo.
Experimental procedure
In the present study, we followed the same experimental procedure (prior interviews, condi-
tions of test room and subjects, and experimental protocol) with our previous studies. As
described in detail previously [16,17], subjects sat in a comfortable chair and remained in the
test room (temperature of approximately 22˚C) for a sufficient period to feel comfortable
before being exposed to the odorants. During the experiments, the subjects closed their eyes
and slowly repeated the Japanese alphabet in an undertone to establish a stable rCBF prior to
olfactory stimulation. They stopped repeating the Japanese alphabet and closed their eyes
Fig 1. Experimental protocol. First, the subjects had a 30-s pre-rest. Then, the subjects were given an
olfactory stimulus for 10 s, followed by a 30-s post-rest period and a 30-s period to complete a questionnaire
on odor intensity and subjective assessments of hedonic and irritating odors. The 130-s cycles for each
odorant were repeated six times consecutively.
doi:10.1371/journal.pone.0168006.g001
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during olfactory stimulation, which lasted for 10 s. Olfactory stimulation was performed after
a 30-s pre-rest period to establish the baseline level (Fig 1). The questionnaire (30 s) on odor
intensity and hedonic and irritating scales was completed immediately after a 30-s rest period
(post-rest) to allow recovery after olfactory stimulation (Fig 1). Afterward, the same process
was repeated for an additional five olfactory stimuli. Odor intensity was rated on a six-point
Likert scale ranging from not at all (0) to strong (5). Hedonic response was rated on a nine-
point Likert scale ranging from discomfort (−4) to comfort (4). Irritation was evaluated on a
visual analog scale, with responses ranging from “not at all” to “strong.”
Olfactory stimuli were applied in the following order: D1, non-odorant (NO), E1, D4, NO,
and E4. The 130-s cycles were repeated six times consecutively. Thus, the order of the six repe-
titions (1–6) was as follows: D1 (1), NO (2), E1 (3), D4 (4), NO (5), and E4 (6).
NIRS data acquisition
Changes in oxygenated hemoglobin (oxyHb) concentrations in the prefrontal area were mea-
sured using the LABNIRS Optical Multi-channel Monitor functional NIRS topography system
(Shimadzu Corporation, Kyoto, Japan). Local blood flow to the relevant brain regions
increases and oxygenated blood displaces deoxygenated blood when neurons become active.
These changes reflect neuronal activity as their levels correlate with evoked changes in rCBF
[32–34]. Pairs of illuminators and detectors were set 3 cm apart in a 3 × 11 lattice pattern to
form 52 channels through a holder set in the prefrontal area. Changes in the oxyHb concentra-
tion were recorded every 54 ms using the NIRS system. Optical data were analyzed on the
basis of the modified Beer–Lambert Law and signals reflecting the oxyHb concentration
changes in an arbitrary unit were calculated (millimolar–millimeter) [35].
Self-reported physical and psychological status
Participants completed a same self-reported questionnaire with our previous studies for the
assessment of physical and psychological parameters. As described in detail previously [16,17],
the questionnaire included the Chemical Sensitivity Scale for Sensory Hyper-reactivity
(CSS-SHR), the Somato-Sensory Amplification Scale (SSAS), the Autonomic Perception Ques-
tionnaire (APQ), the Tellegen Absorption Scale (TAS), the Marlowe–Crowne Social Desirabil-
ity Scale, the Taylor Manifest Anxiety Scale (TMAS), the Negative Affectivity Scale (NAS), and
the Toronto Alexithymia Scale (TAS-20) that evaluates the total score and the scores of the
three subscales, which assess difficulties in identifying feelings (DIF), difficulties in describing
feelings (DDF), and externally-oriented thinking (EOT).
Statistical analyses
OxyHb levels during olfactory stimulation were compared with those during the pre-rest
period as a baseline level in each channel for evaluating the effects of olfactory stimulation on
brain activity [16]. The oxyHb concentrations between the 30-s rest period after olfactory stim-
ulation and the baseline during the pre-rest period were also compared in each channel [17].
The raw data from each channel were converted into z-scores [16,17]. Following the Shapiro–
Wilk normality test and the covariate test for age, the t-test was used to compare brain activity
obtained from NIRS imaging for all channels between patients with MCS and controls and
was applied to analyze the results of self-reported physical and psychological scales to deter-
mine differences between the two groups at baseline. The nonparametric Mann–Whitney U-
test was used to analyze the results of the odor thresholds and olfactory stimulation question-
naires and quantify the differences between two groups. All data analyses were performed
using SPSS statistics software, version 23.
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
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Results
Participants
The participants included 12 patients with MCS (age, 29–65 years; mean, 53.7 ± 9.9 years; all
females) and seven controls (age, 27–55 years; mean, 45.3 ± 9.3 years; all females). Two
patients with MCS did not fulfill the inclusion criterion for QEESI scores, one of whom had a
severe runny and stuffy nose on an experimental day. One control exhibited a high immuno-
globulin E level on hematological examinations. The remaining 10 nonsmoking patients with
MCS (age, 48–65 years; mean, 56.4 ± 6.6 years; all females) and six nonsmoking controls (age,
27–55 years; mean, 44.7 ± 10.0 years; all females) met all the criteria, and they were included in
the analyses. Demographic characteristics of the study population are depicted in Table 1. All
patients with MCS attempted to avoid exposure to odorous chemicals as much as possible.
These patients were homemakers or pensioners. Their occupations included three clerical
employees in offices, a supermarket baker, a teacher, and a fabric tinter. Three controls also
attempted to avoid exposure to odorous chemicals as much as possible. Their occupations
were as follows: a teacher, a company executive, and a homemaker whose previous occupation
was hospital dietician. Three controls did not consciously seek to avoid exposure to odorous
chemicals, and their occupations were a medical coding staff, a teacher, and a graduate student
specializing in clinical psychology.
Odor thresholds
The median T&T detection threshold score for patients with MCS was 0.0 (range, –0.4 to 0.8)
and was –0.1 (range, –0.2 to 0.2) for controls; the difference was not statistically significant.
The median T&T recognition threshold score for patients with MCS was 0.4 (range, 0.0 to
1.2), versus 0.6 (range, 0.0 to 0.8) for controls. This difference was also not statistically signifi-
cant (Fig 2).
NIRS imaging and subjective evaluation of odors
Data for subjective odor intensity and assessments of hedonic and irritating odors by patients
with MCS and controls after olfactory stimulation are shown in Fig 3. In the subjective evalua-
tion, both patients with MCS and controls responded “not at all” on the odor intensity scale,
“undecided” on the hedonic scale, and “not at all” on the irritation scale for both NO (2) and
Table 1. Demographic characteristics of the study population.
MCS (n = 10) Controls (n = 6)
Sex, male/female, (n) 0/10 0/6
Age, mean ± SD, (years) 56.4 ± 6.6 44.7 ± 10.0
Occupation, (n)
Homemakers or pensioners 4 1





Medical coding staff 1
Graduate students 1
doi:10.1371/journal.pone.0168006.t001
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NO (5). These differences between patients with MCS and controls were not statistically
significant.
The odor intensity scores of patients with MCS after exposure to odorants were higher
(sense of stronger) than those of controls, but the differences were not significant. The hedonic
scores of patients with MCS after exposure to odorants were lower (sense of more discomfort)
than those of controls. The difference for D4 (4) was statistically significant. The irritation
scores for patients with MCS after exposure to odorants were higher (sense of stronger) than
those of controls. The difference for D4 (4) was also statistically significant. The differences for
E4 (6) were not significant on either the hedonic or irritation scales, but saturation of the
scores was assumed to be causally related to the results. Overall, odorant E was associated with
stronger odor intensity, more discomfort, and greater irritation than was odorant D.
The time-course of average z-scores of all channels for oxyHb in the MCS and control
groups during pre-rest, stimulation, and post-rest are shown in Fig 4. The results of the t-test
in terms of the average of all channels (1–52) comparing z-scores for oxyHb concentrations
Fig 2. Detection thresholds (A) and recognition thresholds (B) by patients with multiple chemical
sensitivity (MCS) (n = 10) and controls (n = 6) in olfactory ability testing. Y-axes present the mean
values of five odorants.
doi:10.1371/journal.pone.0168006.g002
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between patients with MCS and controls are shown in Table 2. Fig 5 provides the topographi-
cal maps of the average z-scores for oxyHb in patients with MCS and controls. Increases in
rCBF levels in patients with MCS were suppressed after exposure to NO (2) and NO (5). There
was no difference between patients with MCS and controls in responses to PFC. The trend of
Fig 3. Rating of odor intensity (A) as well as hedonic (B) and irritating odors (C) by patients with
multiple chemical sensitivity (MCS) (n = 10) and controls (n = 6) after olfactory stimulation.
Abbreviations: D1, γ-undecalactone and concentration level 1; D4, γ-undecalactone and concentration level
4; E1, skatole and concentration level 1; E4, skatole and concentration level 4; and NO, non-odorant.
Numbers in parentheses in column 1 indicate the order of the six repetitions (1–6). Statistically significant
differences between groups are indicated: *p < 0.05.
doi:10.1371/journal.pone.0168006.g003
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changes of rCBF for D1 (1) was not different between patients with MCS and controls. This
response was observed in our previous studies, and it may have been caused by affective ten-
sion due to the first test [16,17]. For E1 (3), D4 (4), and E4 (6), larger increases in rCBF were
observed in patients with MCS than those on controls, and the differences persisted approxi-
mately 20–30 s after olfactory stimulation. Significant differences in rCBF responses were
observed between patients with MCS and controls during D4 (4) exposure and after E1 (3)
exposure (Table 2). For E1 (3), D4 (4), and E4 (6), the activation (defined as greater increase in
rCBF due to olfactory stimulation) areas of the prefrontal area during [16] and after olfactory
stimulation [17] were similar to the results of our previous studies. These activations after
olfactory stimulation in patients with MCS were especially strong in the lateral OFC (Fig 5).
Self-reported physical and psychological status
The results of the t-test for the physical and psychological scales are presented in S1 Table.
QEESI and CSS-SHR scores were significantly higher for patients with MCS than for controls.
APQ and TAS-20 DIF scores were significantly higher for patients with MCS than for controls.
Fig 4. Time-course of average z-scores of all channels for oxygenated hemoglobin (oxyHb) levels in
patients with multiple chemical sensitivity (MCS) (n = 10) and controls (n = 6) during pre-rest
(baseline, 10–30 s), stimulation (30–40 s), and post-rest (recovery, 40–70 s). Y- and X-axes present the
z-scored oxyHb values and times, respectively. Signals reflecting the oxyHb concentration changes in
arbitrary units were calculated (millimolar–millimeter). The signal data were adjusted using a fast Fourier
transform filter smoothing technique (OriginPro 2016 software of OriginLab Corporation). The cutoff
frequency was determined at 35 points. The MCS group is indicated as a black line, and the control group is
indicated as a gray line. Abbreviations: D1, γ-undecalactone, and concentration level 1; D4, γ-undecalactone,
and concentration level 4; E1, skatole, and concentration level 1; E4, skatole, and concentration level 4; and
NO, non-odorant. Numbers in parentheses in column 1 indicate the order of the six repetitions (1–6).
doi:10.1371/journal.pone.0168006.g004
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No significant differences were observed in the SSAS, TAS, MCSD, TMAS, NAS, TAS-20 total,
TAS-20 DDF and TAS-20 EOT scores.
Discussion
Double-blind provocation challenges in patients with MCS referred by physicians were per-
formed in an environmental chamber and a variety of chemicals such as formaldehyde, natural
gas, cleaners, and combusted kerosene were employed on the basis of the patient’s individual
clinical histories. The exposure concentrations were not allowed to exceed existing threshold
limit values, and clean air was used as a placebo or sham control. None of the patients demon-
strated a reliable response pattern across a series of challenges [19]. Double-blind, placebo-
controlled provocation studies in patients with subjective MCS and matched controls uncov-
ered no objective differences between the groups regarding their reactions to chemical expo-
sure. The subjects were exposed to a mixture of hydrocarbons at the air concentrations set
below an experimentally determined odor threshold [20]. Similar results in single-blind provo-
cation studies for patients with MCS have been reported using formaldehyde and toluene at
air concentrations set below their indoor air quality guidelines and far below their odor thresh-
olds [21,22].
In our study, single-blind provocation challenges were performed during olfactory stimula-
tion at the odor threshold level and normal perceived odor level. Although the differences
between patients with MCS and controls in both odor detection and recognition thresholds
were not significant, greater increases in rCBF were observed in patients with MCS than in
controls during olfactory stimulation at the recognition threshold or normally perceived level,
and the differences persisted approximately 20–30 s after olfactory stimulation. The activation
areas were the PFC during olfactory stimulation and the OFC after olfactory stimulation. Our
results therefore suggest that the symptoms of MCS are not the reactions to chemical exposure
at levels far below the odor thresholds, and the reflexive brain response to odor perceived
instead involves the physical reactions of patients with MCS. When the odor recognition
Table 2. The t-test results for all channels (1–52) comparing z-scores for oxygenated hemoglobin levels between patients with multiple chemical
sensitivity (MCS) and controls.
Test MCS (n = 10) Controls (n = 6) p value
Stimulus D1 (1) 0.44 (0.48) 0.55 (0.59) 0.693
NO (2) −0.01 (0.31) −0.20 (0.57) 0.468
E1 (3) 0.27 (0.33) −0.04 (0.62) 0.208
D4 (4) 0.23 (0.32) −0.28 (0.23) 0.004*
NO (5) 0.27 (0.45) −0.23 (0.51) 0.062
E4 (6) 0.34 (0.36) −0.27 (0.81) 0.054
Recovery D1 (1) 0.56 (0.63) 0.77 (0.60) 0.524
NO (2) 0.23 (0.62) 0.02 (0.50) 0.482
E1 (3) 1.00 (0.75) 0.01 (0.56) 0.014*
D4 (4) 0.79 (1.06) 0.34 (1.14) 0.431
NO (5) 0.34 (0.62) −0.30 (1.13) 0.166
E4 (6) 0.82 (0.48) 0.18 (1.46) 0.221
Values are expressed as means (± standard deviations).
* Significant at p < 0.05.
Abbreviations: D1, γ-undecalactone and concentration level 1; D4, γ-undecalactone and concentration level 4; E1, skatole and concentration level 1; E4,
skatole and concentration level 4; and NO, non-odorant. Numbers in parentheses in column 1 indicate the order of the six repetitions (1–6).
doi:10.1371/journal.pone.0168006.t002
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threshold exceeds the health-based threshold (i.e., no-observed adverse effect level), the air
concentration of chemicals at the odor recognition threshold has harmful effects in the general
population. However, when the health-based threshold exceeds the odor recognition thresh-
old, the air concentration of chemicals at the odor recognition threshold is lower than those
established to have harmful effects in the general population.
Olfactory input has direct connections via the olfactory bulb and primary olfactory (piri-
form) cortex to the amygdala and hippocampus. From these areas, sensory information is con-
veyed to the secondary olfactory cortices composed of the OFC and insular cortex [36].
Human episodic memory is the long-term memory process that enables one to mentally and
consciously relive specific personal events from the past [37,38]. The PFC regulates the
Fig 5. Topographical maps of average z-scores for oxygenated hemoglobin (oxyHb) levels between
patients with multiple chemical sensitivity (MCS) (n = 10) and controls (n = 6). Abbreviations: D1, γ-
undecalactone, and concentration level 1; D4, γ-undecalactone, and concentration level 4; E1, skatole, and
concentration level 1; E4, skatole, and concentration level 4; and NO, non-odorant. Numbers in parentheses
in column 1 indicate the order of the six repetitions (1–6).
doi:10.1371/journal.pone.0168006.g005
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formation and control of memory [39]. In particular, the PFC has been linked to cognitive
control processes such as selection, engagement, monitoring, and inhibition in long-term
memory [40], and it plays an important role in long-term odor memory [41,42]. Odors are
powerful cues that trigger episodic memories. Episodic odor memory has extremely little long-
term loss compared with memories of pictures or odor presented in a laboratory environment
[43]. Among all sensory stimuli, odors appear to trigger the most vivid and emotional memo-
ries [44]. For the sense of smell, emotional processing related to stimulation or discomfort pre-
vails in comparison to verbal or writing processing, and the consequence of the processing
rapidly appears [36,43].
Patients with MCS exhibit stronger physical reactions to odors at normally perceived levels
in daily life than healthy people do. The status persists due to repeated daily exposure to the
odors, and they exhibit physical intolerance to odorous chemicals at levels less than those
established to have harmful effects in the general population. Our results including the present
study suggested that the change of odor information processing associated with odor-process-
ing neuronal circuits and memory and cognition processes due to prior hazardous chemical
exposure play significant roles in the chemical-sensitive state of patients with MCS [16,17].
The present study indicated that activation of rCBF in the PFC and OFC in patients with MCS
could be observed during exposure to odors at the recognition threshold level. In this study,
the first symptoms were triggered by the initial exposure to chemicals in seven patients with
MCS. These included the use of organic solvents, pesticides or incense in the workplace; the
use of diesel machines in the neighborhood; or chemical exposure after renovation of a house
or moving into a newly built house. Three patients had episodes of repeated exposure to sol-
vents emitted from a neighboring industrial plant or paint store or fragrances or pesticides
emitted in the neighborhood. Patients with MCS subsequently complained about a chemical
sensitive condition.
The dorsal part of the anterior cingulate cortex (ACC) is connected to the PFC, and it plays
an important role in processing top-down and bottom-up stimuli and assigning appropriate
control to other areas in the brain [45]. Thus, the past exposure event was stored as memories
in these cortices through olfactory nerve circuits, the processing of top-down stimuli from
these cortices involves the central system related to emotional and autonomic nervous system,
and various physical or psychological symptoms would be induced in patients with MCS. The
psychological evaluations in the present study indicated that scores in MCS patients were sig-
nificantly higher than those in controls on the APQ and TAS-20 DIF scales. These results also
may support the theory of response regulation by memory in the PFC. Andersson et al further-
more suggested the involvement of a limbic hyperreactivity and speculatively described the
sensitivity with MCS as an inability to inhibit salient external stimuli in MCS [46].
Near-infrared rays sent out from the NIRS device can provide visual access to the cerebral
cortex within approximately 20 mm from the scalp, but cannot access the deep portion of a
cerebral limbic system. The NIRS has the advantage of a high time resolution and the feasibil-
ity of being performed under natural conditions compared with other functional neuroimag-
ing methodologies such as fMRI, PET, and SPECT, which can access the cerebral limbic
system. However, the connections between the cerebral cortex and cerebral limbic system,
their odor information processing, and their associations with MCS symptoms are important
to clarify the pathology of this disorder. Further research is necessary regarding these connec-
tions and their associations with the symptoms using the NIRS and these other methodologies
during olfactory stimulation.
Our study had some limitations. First, the small sample size makes the results vulnerable to
selection bias. This could be alleviated by including a larger study population. However, differ-
ences between the patients with MCS and the controls regarding the NIRS imaging data were
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evident and supported by similar findings in the ACC [13], PFC [16], and OFC [17] in previ-
ous studies. Second, to the best of our knowledge, this is the first case-control study investigat-
ing the association of odor thresholds and changes in rCBF in prefrontal areas during
olfactory stimulation at the odor threshold level in patients with MCS using NIRS imaging.
Further evaluation using several odorants associated with a wide range of levels of comfort/dis-
comfort or weak/strong irritation for MCS would provide valuable information for under-
standing the pathology of this disorder. A third limitation was the lack of standardized
objective measures to identify and define MCS. Most definitions of MCS are entirely qualita-
tive, relying on subjective reports of distressing symptoms and environmental exposure from
patients and physicians. Therefore, several participants were excluded on the basis of QEESI
scores, hematological data, and the discretion of the clinic physician due to conditions such as
mental or chronic disorders.
In conclusion, despite the small sample size, this experimental case-control study demon-
strated that significant differences between patients with MCS and controls regarding odor
thresholds were not observed, and larger increases in rCBF in the PFC and OFC were observed
in patients with MCS than in controls in response to the olfactory stimuli at the odor recogni-
tion threshold or normally perceived odor level. These brain responses may involve cognitive
and memory processing systems during past exposure to hazardous chemicals. Further
research regarding the mode of action of chemical sensitivity through the cerebral limbic sys-
tem due to chemicals that were recognized as harmful or hazardous during the past exposure
event is needed.
Supporting Information
S1 Table. Results of the t-test for the physical and psychological scales.
(DOCX)
Acknowledgments
This study was financially supported by a health science research grant (H25-5962) from the
Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences
Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. We
express our sincere appreciation to the staff members of the Hyakumanben Clinic for their
assistance in data collection.
Author Contributions
Conceptualization: KA IU MT IB MA HT TY KS.
Data curation: KA IU MT IB MA.
Formal analysis: KA IB MA.
Funding acquisition: KS.
Investigation: KA IU MT IB MA.
Methodology: KA IU MT IB MA HT TY KS.
Project administration: KA IU KS.
Resources: KA IU MT IB MA.
Supervision: KA IU KS.
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
PLOS ONE | DOI:10.1371/journal.pone.0168006 December 9, 2016 13 / 16
Validation: KA IU MT IB MA HT TY KS.
Writing – original draft: KA IU.
Writing – review & editing: KA IU MT IB MA HT TY KS.
References
1. Cullen MR (1987) The worker with multiple chemical sensitivities: an overview. Occup Med 2:655–61.
2. Graveling RA, Pilkington A, George JP, Butler MP, Tannahill SN (1999) A review of multiple chemical
sensitivity. Occup Environ Med 56:73–85. PMID: 10448311
3. Winder C (2002) Mechanisms of multiple chemical sensitivity. Toxicol Lett 128:85–97. PMID:
11869820
4. Dantoft TM, Andersson L, Nordin S, Skovbjerg S (2015) Chemical Intolerance. Curr Rheumatol Rev
11:167–84. PMID: 26088215
5. Miller CS, Prihoda TJ (1999) The environmental exposure and sensitivity inventory (EESI): a standard-
ized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind
Health 15: 370–85. PMID: 10416289
6. Skovbjerg S, Berg ND, Elberling J, Christensen KB (2012) Evaluation of the Quick Environmental Expo-
sure and Sensitivity Inventory in a Danish population. J Environ Publ Health. 2012: Article ID 304314.
7. Azuma K, Uchiyama I, Katoh T, Ogata H, Arashidani K, Kunugita N (2015) Prevalence and characteris-
tics of chemical intolerance: a Japanese population-based study. Arch Environ Occup Health 70:341–
53. doi: 10.1080/19338244.2014.926855 PMID: 25137616
8. Sorg BA (1999) Multiple chemical sensitivity: potential role for neural sensitization. Crit Rev Neurobiol
13:283–316. PMID: 10803638
9. Berg ND, Linneberg A, Dirksen A, Elberling J (2008) Prevalence of self-reported symptoms and conse-
quences related to inhalation of airborne chemicals in a Danish general population. Int Arch Occup Envi-
ron Health 81:881–7. doi: 10.1007/s00420-007-0282-0 PMID: 18058120
10. Berg ND, Linneberg A, Dirksen A, Elberling J (2009) Phenotypes of individuals affected by airborne
chemicals in the general population. Int Arch Occup Environ Health 82:509–17. doi: 10.1007/s00420-
008-0352-y PMID: 18751996
11. Lacour M, Zunder T, Schmidtke K, Vaith P, Scheidt C (2005) Multiple chemical sensitivity syndrome
(MCS)–suggestions for an extension of the U.S. MCS-case definition. Int J Hyg Environ Health
208:141–51. doi: 10.1016/j.ijheh.2005.01.017 PMID: 15971853
12. Orriols R, Costa R, Cuberas G, Jacas C, Castell J, Sunyer J (2009) Brain dysfunction in multiple chemi-
cal sensitivity. J Neurol Sci 287:72–8. doi: 10.1016/j.jns.2009.09.003 PMID: 19801154
13. Hillert L, Musabasic V, Berglund H, Ciumas C, Savic I (2007) Odor processing in multiple chemical sen-
sitivity. Hum Brain Mapp 28:172–82. doi: 10.1002/hbm.20266 PMID: 16767766
14. Chiaravalloti A, Pagani M, Micarelli A, Di Pietro B, Genovesi G, Alessandrini M, et al. (2015) Cortical
activity during olfactory stimulation in multiple chemical sensitivity: A (18)F-FDG PET/CT study. Eur J
Nucl Med Mol Imaging 42:733–40. doi: 10.1007/s00259-014-2969-2 PMID: 25690545
15. Alessandrini M, Micarelli A, Chiaravalloti A, Bruno E, Danieli R, Pierantozzi M, et al. (2016) Involvement
of subcortical brain structures during olfactory stimulation in multiple chemical sensitivity. Brain Topogr
29:243–52. doi: 10.1007/s10548-015-0453-3 PMID: 26438099
16. Azuma K, Uchiyama I, Takano H, Tanigawa M, Azuma M, Bamba I, et al. (2013) Changes in Cerebral
Blood Flow during Olfactory Stimulation in Patients with Multiple Chemical Sensitivity: A Multi-Channel
Near-Infrared Spectroscopic Study. PLoS ONE 8(11): e80567. doi: 10.1371/journal.pone.0080567
PMID: 24278291
17. Azuma K, Uchiyama I, Tanigawa M, Bamba I, Azuma M, Takano H, et al. (2015) Assessment of cere-
bral blood flow in patients with multiple chemical sensitivity using near-infrared spectroscopy—recovery
after olfactory stimulation: a case–control study. Environ Health Prev Med 20:185–94. doi: 10.1007/
s12199-015-0448-4 PMID: 25682122
18. Das-Munshi J, Rubin GJ, Wessely S (2006) Multiple chemical sensitivities: A systematic review of prov-
ocation studies. J Allergy Clin Immunol 118:1257–64. doi: 10.1016/j.jaci.2006.07.046 PMID: 17137865
19. Staudenmayer H, Selner JC, Buhr MP (1993) Double-blind provocation chamber challenges in 20
patients presenting with “multiple chemical sensitivity”. Regul Toxicol Pharmacol 18:44–53. doi: 10.
1006/rtph.1993.1043 PMID: 8234918
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
PLOS ONE | DOI:10.1371/journal.pone.0168006 December 9, 2016 14 / 16
20. Bornschein S, Hausteiner C, Ro¨mmelt H, Nowak D, Fo¨rstl H, Zilker T (2008) Double-blind placebo-con-
trolled provocation study in patients with subjective Multiple Chemical Sensitivity (MCS) and matched
control subjects. Clin Toxicol (Phila) 46:443–9.
21. Hasegawa M, Ohtomo M, Mizuki M, Akiyama K (2009) Diagnosis of multiple chemical sensitivity by
chemical compounds exposure tests. Japanese Journal of Allergology 58:112–8. PMID: 19329873
22. Yoshida T, Hirata M, Ofawa M (2012) Single-blind provocation test including exposure to formaldehyde
and toluene for patients with idiopathic environmental intolerance. Japanese journal of occupational
medicine and traumatology 60:11–7.
23. Anonymous (1999) Multiple chemical sensitivity: a 1999 Consensus. Arch Environ Health 54:147–49.
doi: 10.1080/00039899909602251 PMID: 10444033
24. Zusho H (1983) Olfactometry in Japan. Rhinology 21:281–5. PMID: 6635477
25. Ikeda L, Sakurada T, Sasaki Y, Takasawa T, Furukawa Y (1988) Clinical investigation of olfactory and
auditory function in type I pseudo-hypoparathroidism: participation of adenylate cyclase system. J Lar-
nygol Otol 102: 1111–4.
26. Zusho H, Asaka H, Okamoto M (1981) Diagnosis of olfactory disturbance. Auris Nasus Larynx 8:19–
26. PMID: 6269522
27. Fujii M, Fukazawa K, Takayasu S, Sakagami M (2002) Olfactory dysfunction in patients with head
trauma. Auris Nasus Larynx 27:35–40.
28. Doty RL, Smith R, McKeown DA, Raj J (1994) Tests of human olfactory function: principal components
analysis suggests that most measure a common source of variance. Percept Psychophys 56:701–7.
PMID: 7816540
29. Kondo H, Matsuda T, Hashiba M, Baba S (1998) A study of the relationship between the T&T olfactome-
ter and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol
12:353–8. PMID: 9805536
30. Hashimoto Y, Fukazawa K, Fujii M, Takayasu S, Muto T, Saito S, et al. (2004) Usefulness of the odor
stick identification test for Japanese patients with olfactory dysfunction. Chem Senses 29:565–71. doi:
10.1093/chemse/bjh061 PMID: 15337682
31. Takagi SF (1987) A standardized olfactometer in Japan. Ann NY Acad Sci 510:113–8. PMID: 3481235
32. Hock C, Mu¨ller-Spahn F, Schuh-Hofer S, Hofmann M, Dirnagl U, Villringer A (1995) Age dependency of
changes in cerebral hemoglobin oxygenation during brain activation: a near-infrared spectroscopy
study. J Cereb Blood Flow Metab 15:1103–08. doi: 10.1038/jcbfm.1995.137 PMID: 7593343
33. Kameyama M, Fukuda M, Yamagishi Y, Sato T, Uehara T, Ito M, et al. (2006) Frontal lobe function in
bipolar disorder: a multichannel near-infrared spectroscopy study. Neuroimage 29:172–84. doi: 10.
1016/j.neuroimage.2005.07.025 PMID: 16125979
34. Tanida M, Sakatani K, Takano R, Tagai K (2004) Relation between asymmetry of prefrontal cortex
activities and the autonomic nervous system during a mental arithmetic task: near infrared spectroscopy
study. Neurosci Lett 369:69–74. doi: 10.1016/j.neulet.2004.07.076 PMID: 15380310
35. Okamoto M, Matsunami M, Dan H, Kohata T, Kohyama K, Dan I (2006) Prefrontal activity during taste
encoding: an fNIRS study. Neuroimage 31:796–806. doi: 10.1016/j.neuroimage.2005.12.021 PMID:
16473020
36. Saive AL, Royet JP, Plailly J (2014) A review on the neural bases of episodic odor memory: from labora-
tory-based to autobiographical approaches. Front Behav Neurosci 8:240. doi: 10.3389/fnbeh.2014.
00240 PMID: 25071494
37. Tulving E (1972) “Episodic and semantic memory,” in Organization of Memory, eds Tulving E. and
Donaldson W. ( New York: Academic Press), 381–403.
38. Tulving E (1984) Pre´cis of Elements of episodic memory. Behav Brain Sci 7:223–68.
39. Tulving E (2002) Episodic memory: from mind to brain. Annu Rev Psychol 53:1–25. doi: 10.1146/
annurev.psych.53.100901.135114 PMID: 11752477
40. Simons JS, Spiers HJ (2003) Prefrontal and medial temporal lobe interactions in long-term memory.
Nat Rev Neurosci 4:637–48. doi: 10.1038/nrn1178 PMID: 12894239
41. Savic I, Gulyas B, Larsson M, Roland P (2000) Olfactory functions are mediated by parallel and hierar-
chical processing. Neuron 26:735–45. PMID: 10896168
42. Dade LA, Zatorre RJ, Jones-Gotman M (2002) Olfactory learning: convergent findings from lesion and
brain imaging studies in humans. Brain 125(Pt 1):86–101. PMID: 11834595
43. Engen T (1987) Remembering odors and their names. Amer Scientist 75: 497–503.
44. Hinton PB, Henley TB (1993) Cognitive and affective components of stimuli presented in three modes.
Bull Psychon Soc 31:595–8.
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
PLOS ONE | DOI:10.1371/journal.pone.0168006 December 9, 2016 15 / 16
45. Etkin A, Egner T, Kalisch R (2011) Emotional processing in anterior cingulate and medial prefrontal cor-
tex. Trends Cogn Sci 15:85–93. doi: 10.1016/j.tics.2010.11.004 PMID: 21167765
46. Andersson L, Claeson AS, Nyberg L, Stenberg B, Nordin S (2014) Brain responses to olfactory and tri-
geminal exposure in idiopathic environmental illness (IEI) attributed to smells–An fMRI study. J Psycho-
som Res 77:401–8. doi: 10.1016/j.jpsychores.2014.09.014 PMID: 25294782
Odor Thresholds and Responses in Cerebral Blood Flow in MCS Patients
PLOS ONE | DOI:10.1371/journal.pone.0168006 December 9, 2016 16 / 16
